Back to Search
Start Over
GABA A receptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus.
- Source :
-
Journal of neurochemistry [J Neurochem] 2018 Jun; Vol. 145 (5), pp. 374-392. - Publication Year :
- 2018
-
Abstract
- Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system. GABA type A receptors (GABA <subscript>A</subscript> Rs) are severely affected in Alzheimer's disease (AD). However, the distribution and subunit composition of GABA <subscript>A</subscript> Rs in the AD brain are not well understood. This is the first comprehensive study to show brain region- and cell layer-specific alterations in the expression of the GABA <subscript>A</subscript> R subunits α1-3, α5, β1-3 and γ2 in the human AD hippocampus, entorhinal cortex and superior temporal gyrus. In late-stage AD tissue samples using immunohistochemistry we found significant alteration of all investigated GABA <subscript>A</subscript> Rs subunits except for α3 and β1 that were well preserved. The most prominent changes include an increase in GABA <subscript>A</subscript> R α1 expression associated with AD in all layers of the CA3 region, in the stratum (str.) granulare and hilus of the dentate gyrus. We found a significant increase in GABA <subscript>A</subscript> R α2 expression in the str. oriens of the CA1-3, str. radiatum of the CA2,3 and decrease in the str. pyramidale of the CA1 region in AD cases. In AD there was a significant increase in GABA <subscript>A</subscript> R α5 subunit expression in str. pyramidale, str. oriens of the CA1 region and decrease in the superior temporal gyrus. We also found a significant decrease in the GABA <subscript>A</subscript> R β3 subunit immunoreactivity in the str. oriens of the CA2, str. granulare and str. moleculare of the dentate gyrus. In conclusion, these findings indicate that the expression of the GABA <subscript>A</subscript> R subunits shows brain region- and layer-specific alterations in AD, and these changes could significantly influence and alter GABA <subscript>A</subscript> R function in the disease. Cover Image for this issue: doi: 10.1111/jnc.14179.<br /> (© 2018 International Society for Neurochemistry.)
Details
- Language :
- English
- ISSN :
- 1471-4159
- Volume :
- 145
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of neurochemistry
- Publication Type :
- Academic Journal
- Accession number :
- 29485232
- Full Text :
- https://doi.org/10.1111/jnc.14325